Intraplatelet cyclic guanosine-3′,5′-monophosphate levels during pregnancy and preeclampsia

Hypertension in Pregnancy

Volumn 23, Issue 3, 2004, Pages 303-308

  Teran, Enrique ^a   Escudero, Carlos ^a   Vivero, Sandra ^a   Enriquez, Armando ^b   Calle, Andres ^b  

^a UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

^b Hospital Gineco Obstetrico Isidro Ayora   (Ecuador)

Author keywords

cGMP; Nitric oxide; Platelets; Preeclampsia; Pregnancy

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD LEVEL; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC ELEVATION; HIGH RISK POPULATION; HUMAN; PREECLAMPSIA; PREGNANCY; THROMBOCYTE;

ADULT; BLOOD PLATELETS; CYCLIC GMP; FEMALE; HUMANS; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY;

EID: 9244228531     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-200030860     Document Type: Article

References (26)

1. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of pre-eclampsia. Clin Perinatol 1991; 4:661-682.
2. Weiner C, Knowles R, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994; 171:838-843.
3. Miller V. Vascular control during pregnancy. Extending experimental findings to humans. Circ Res 2000; 87:344-345.
4. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272:R441-R463.
5. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996; 174:1008-1013.
6. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi KI, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 1996; 41:189-193.
7. Moncada S, Higgs EA. The L-arginine: nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
8. Hobbs AJ, Ignarro LJ. Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol 1996; 269:134-148.
9. Hobbs AJ. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 1997; 18:484-491.
10. Hobbs AJ. Soluble guanylate cyclase: an old therapeutic target re-visited. Br J Pharmacol 2002; 136:637-640.
11. Yallampalli C, Garfield R. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:1316-1320.
12. Conrad KP, Joffe GM, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7:556-571.
13. x diet. Am J Physiol 1999; 277:F48-F57.
14. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of NO in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171:944-948.
15. Silver RK, Kupferminc MJ, Russell TL, Adler L, Mullen TA, Caplan MS. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 1996; 175:1013-1017.
16. Konijnenberg A, van der Post J, Mol B, Schaap MC, Lazarov R, Bleker OP, Boer K, Sturk A. Can flow cytometric detection of platelet activation early predict the occurrence of pre-eclampsia? Am J Obstet Gynecol 1997; 177:434-442.
17. Hutt R, Ogunniyi S, Sullivan M, Elder MG. Increased platelet volume and aggregation precede the onset of pre-eclampsia. Obstet Gynecol 1994; 83:146-149.
18. Yusuf A, van Iddeking B, Paul C, Sullivan HF, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1993; 100:216-220.
19. Teran E, Escudero C, Vivero S. Physiological changes in platelet aggregation and nitric oxide levels during menstrual cycle in healthy women. Nitric Oxide 2002; 7:217-220.
20. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989; 96:648-655.
21. Norris L, Sheppard B, Burke G, et al. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1994; 101:209-214.
22. Boehlen F, Hohlfeld P, Extermann P, Perneger T, De Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 2000; 95:29-33.
23. Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH. Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet Gynecol 2002; 19:443-448.
24. Hardy E, Rubin PC, Horn EH. Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in pre-eclampsia. Clin Sci (Lond) 1994; 86:195-202.
25. Neri I, Piccinini F, Marietta M, Facchinetti F, Volpe A. Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertens Pregnancy 2000; 19:323-330.
26. Lopez-Jaramillo P, Narvaez A, Calle J, Rivera J, Jácome P, Ruano C, Nava E. Cyclic guanosine-3′,5′-monophosphate concentrations in preeclampsia: effects of hydralazine. Br J Obstet Gynaecol 1996; 103:33-38.